A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma (Q41605727)

5 October 2017

1 reference

title

A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma (English)

1 reference

5 October 2017

1 reference

D. Machover

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9317168

18 November 2024

language of work or name

English

0 references

publication date

1 October 1997

1 reference

full work available at URL

5 October 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9317168

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

18 November 2024

1 reference

5 October 2017

1 reference

5 October 2017

1 reference

5 October 2017

page(s)

1179-1187

1 reference

5 October 2017

cites work

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The Surgical Pathology of Rectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The effect of dose and interval between 5-fluorouracil and leucovorin on the formation of thymidylate synthase ternary complex in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

Role of leucovorin dosing and administration schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819971001%2980%3A7%3C1179%3A%3AAID-CNCR1%3E3.0.CO%3B2-G

IARC scientific publications

21 January 2018

121

Coleman

1993

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Cancer of the colon: the influence of the no-touch isolation technic on survival rates

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Relationship between fluorouracil systemic exposure and tumor response and patient survival

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

18 November 2024

2100

Borner

1996

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

5-Fluorouracil and low-dose leucovorin in metastatic colorectal cancer: a pilot study

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Treatment of advanced colorectal cancer with high-dose intensity folinic acid and 5-fluorouracil plus supportive care

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the Germa

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Fluorouracil Combined With the Pure (6S)-Stereoisomer of Folinic Acid in High Doses for Treatment of Patients With Advanced Colorectal Carcinoma: A Phase I-II Study

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancer

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Biochemical modulation of fluoropyrimidines: is there an optimal (6R,S) leucovorin dose and schedule?

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

18 November 2024

1 reference

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

https://api.crossref.org/works/10.1002/(SICI)1097-0142(19971001)80:7%3C1179::AID-CNCR1%3E3.0.CO;2-G

18 November 2024

Identifiers

10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G

1 reference

5 October 2017

1 reference